New opportunities for the management and therapy of hepatitis C in correctional settings.
Hepatitis C in prison populations is now a major public health problem, and large numbers of correctional facilities have no comprehensive management program, often because of formidable projected costs and tightening budget constraints. The North Dakota Department of Corrections and Rehabilitation has operated a management and therapy program since 2002 using consensus interferon and ribavirin with 45% cost savings. The program has provided excellent sustained viral responses: 54.2% for genotype 1 hepatitis C, 75% for genotypes 2 and 3, and 63.6% overall.
Medcenter One Health Systems, 222 N 7th St, Bismark, ND 58501, USA. email@example.com
SourceAmerican journal of public health 100:1 2010 Jan pg 13-7
Health Care Costs
Interferon Type I, Recombinant
Pub Type(s)Journal Article
Research Support, Non-U.S. Gov't